Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor

Fernandez-Catalan C, Bode W, Huber R, Turk D, Calvete JJ, Lichte A, Tschesche H, Maskos K (1998)
EMBO JOURNAL 17(17): 5238-5248.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Fernandez-Catalan, C; Bode, W; Huber, R; Turk, D; Calvete, JJ; Lichte, A; Tschesche, HaraldUniBi; Maskos, K
Abstract / Bemerkung
The proteolytic activity of matrix metalloproteinases (MMPs) towards extracellular matrix components is held in check by the tissue inhibitors of metalloproteinases (TIMPs). The binary complex of TIMP-2 and membrane-type-1 MMP (MT1-MMP) forms a cell surface located 'receptor' involved in pro-MMP-2 activation. We have solved the 2.75 Angstrom crystal structure of the complex between the catalytic domain of human MT1-MMP (cdMT1-MMP) and bovine TIMP-2. In comparison with our previously determined MMP-3-TIMP-1 complex, both proteins are considerably tilted to one another and show new features. CdMT1-MMP, apart from exhibiting the classical MMP fold, displays two large insertions remote from the active-site cleft that might be important for interaction with macromolecular substrates. The TIMP-2 polypeptide chain, as in TIMP-1, folds into a continuous wedge; the A-B edge loop is much more elongated and tilted, however, wrapping around the S-loop and the beta-sheet rim of the MT1-MMP, In addition, both C-terminal edge loops make more interactions with the target enzyme. The C-terminal acidic tail of TIMP-2 is disordered but might adopt a defined structure upon binding to pro-MMP-2; the Ser2 side-chain of TIMP-2 extends into the voluminous S1' specificity pocket of cdMT1-MMP, with its O gamma pointing towards the carboxylate of the catalytic Glu240. The lower affinity of TIMP-1 for MT1-MMP compared with TIMP-2 might be explained by a reduced number of favourable interactions.
Stichworte
crystal structure; progelatinase A activator; proteinase complex; tissue inhibitor of metalloproteinases; matrix metalloproteinase
Erscheinungsjahr
1998
Zeitschriftentitel
EMBO JOURNAL
Band
17
Ausgabe
17
Seite(n)
5238-5248
ISSN
0261-4189
eISSN
1460-2075
Page URI
https://pub.uni-bielefeld.de/record/1624817

Zitieren

Fernandez-Catalan C, Bode W, Huber R, et al. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. EMBO JOURNAL. 1998;17(17):5238-5248.
Fernandez-Catalan, C., Bode, W., Huber, R., Turk, D., Calvete, J. J., Lichte, A., Tschesche, H., et al. (1998). Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. EMBO JOURNAL, 17(17), 5238-5248. https://doi.org/10.1093/emboj/17.17.5238
Fernandez-Catalan, C, Bode, W, Huber, R, Turk, D, Calvete, JJ, Lichte, A, Tschesche, Harald, and Maskos, K. 1998. “Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor”. EMBO JOURNAL 17 (17): 5238-5248.
Fernandez-Catalan, C., Bode, W., Huber, R., Turk, D., Calvete, J. J., Lichte, A., Tschesche, H., and Maskos, K. (1998). Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. EMBO JOURNAL 17, 5238-5248.
Fernandez-Catalan, C., et al., 1998. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. EMBO JOURNAL, 17(17), p 5238-5248.
C. Fernandez-Catalan, et al., “Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor”, EMBO JOURNAL, vol. 17, 1998, pp. 5238-5248.
Fernandez-Catalan, C., Bode, W., Huber, R., Turk, D., Calvete, J.J., Lichte, A., Tschesche, H., Maskos, K.: Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. EMBO JOURNAL. 17, 5238-5248 (1998).
Fernandez-Catalan, C, Bode, W, Huber, R, Turk, D, Calvete, JJ, Lichte, A, Tschesche, Harald, and Maskos, K. “Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor”. EMBO JOURNAL 17.17 (1998): 5238-5248.

132 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Insights into MMP-TIMP interactions.
Bode W, Fernandez-Catalan C, Grams F, Gomis-Rüth FX, Nagase H, Tschesche H, Maskos K., Ann N Y Acad Sci 878(), 1999
PMID: 10415721
Tissue inhibitors of matrix metalloproteinases in cancer.
Blavier L, Henriet P, Imren S, Declerck YA., Ann N Y Acad Sci 878(), 1999
PMID: 10415723
Analysis of the interaction of TIMP-2 and MMPs: engineering the changes.
Hutton M, Butler GS, Wattam BA, Willenbrock F, Williamson RA, Murphy G., Ann N Y Acad Sci 878(), 1999
PMID: 10415762
Matrix metalloproteinases.
Nagase H, Woessner JF., J Biol Chem 274(31), 1999
PMID: 10419448
Membrane associated matrix metalloproteinases in metastasis.
Ellerbroek SM, Stack MS., Bioessays 21(11), 1999
PMID: 10517867
Three-dimensional structure of human tissue inhibitor of metalloproteinases-2 at 2.1 A resolution.
Tuuttila A, Morgunova E, Bergmann U, Lindqvist Y, Maskos K, Fernandez-Catalan C, Bode W, Tryggvason K, Schneider G., J Mol Biol 284(4), 1998
PMID: 9837731

47 References

Daten bereitgestellt von Europe PubMed Central.

Tissue inhibitors of matrix metalloendopeptidases.
Murphy G, Willenbrock F., Meth. Enzymol. 248(), 1995
PMID: 7674941
Activation mechanisms of matrix metalloproteinases.
Nagase H., Biol. Chem. 378(3-4), 1997
PMID: 9165065
Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules.
Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y., J. Biol. Chem. 272(4), 1997
PMID: 8999957
Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.
Okada A, Bellocq JP, Rouyer N, Chenard MP, Rio MC, Chambon P, Basset P., Proc. Natl. Acad. Sci. U.S.A. 92(7), 1995
PMID: 7708715
Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases.
d'Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G., Eur. J. Biochem. 250(3), 1997
PMID: 9461298
Structural implications for the role of the N terminus in the 'superactivation' of collagenases. A crystallographic study.
Reinemer P, Grams F, Huber R, Kleine T, Schnierer S, Piper M, Tschesche H, Bode W., FEBS Lett. 338(2), 1994
PMID: 8307185
A matrix metalloproteinase expressed on the surface of invasive tumour cells.
Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M., Nature 370(6484), 1994
PMID: 8015608
Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family.
Stetler-Stevenson WG, Krutzsch HC, Liotta LA., J. Biol. Chem. 264(29), 1989
PMID: 2793861
Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2.
Strongin AY, Marmer BL, Grant GA, Goldberg GI., J. Biol. Chem. 268(19), 1993
PMID: 8314771
Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease.
Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI., J. Biol. Chem. 270(10), 1995
PMID: 7890645
The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A.
Willenbrock F, Crabbe T, Slocombe PM, Sutton CW, Docherty AJ, Cockett MI, O'Shea M, Brocklehurst K, Phillips IR, Murphy G., Biochemistry 32(16), 1993
PMID: 8476862
Solution structure of the active domain of tissue inhibitor of metalloproteinases-2. A new member of the OB fold protein family.
Williamson RA, Martorell G, Carr MD, Murphy G, Docherty AJ, Freedman RB, Feeney J., Biochemistry 33(39), 1994
PMID: 7918391
Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP).
Zucker S, Drews M, Conner C, Foda HD, DeClerck YA, Langley KE, Bahou WF, Docherty AJ, Cao J., J. Biol. Chem. 273(2), 1998
PMID: 9422789
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 9724659
PubMed | Europe PMC

Suchen in

Google Scholar